Please login to the form below

Not currently logged in
Email:
Password:

immunotherapy

This page shows the latest immunotherapy news and features for those working in and with pharma, biotech and healthcare.

Keytruda doubles five-year survival rate in NSCLC

Keytruda doubles five-year survival rate in NSCLC

Merck reveals long-term efficacy data for blockbuster immunotherapy. Merck &Co/MSD’s Keytruda (pembrolizumab) doubled the five-year survival rate for patients with metastatic non-small cell lung cancer (NSCLC) ... Since then, the immunotherapy has

Latest news

More from news
Approximately 96 fully matching, plus 506 partially matching documents found.

Latest Intelligence

  • Cortellis Drugs to Watch in 2020 report Cortellis Drugs to Watch in 2020 report

    Liso-cel (lisocabtagene maraleucel, JCAR-017) is an immunotherapy comprised of autologous T cells genetically modified (via lentiviral vector) to express an anti-CD19 chimeric antigen receptor (CAR).

  • Pharma funding and M&A in 2020 Pharma funding and M&A in 2020

    Indeed, 2019 was notable for Bristol-Myers Squibb’s acquisition of Celgene (which at a stroke bolstered its immunotherapy and oncology departments), as well as AbbVie’s acquisition of Allergan for ... Indeed, a key theme of the deals I have mentioned

  • It started with a miss It started with a miss

    However, we’re now moving into areas like immunotherapy and are on the edge of amazing innovations that will deliver great outcomes for patients.

  • A snapshot of Microbiotica A snapshot of Microbiotica

    An area of high interest is the discovery that responses to cancer immunotherapy are dependent on gut bacteria.

  • Rethinking trials: the pros and cons of protocol amendments Rethinking trials: the pros and cons of protocol amendments

    This view is shared by Chris Learn, who said immunotherapy studies are more prone to amendments than other types of research.

More from intelligence
Approximately 5 fully matching, plus 55 partially matching documents found.

Latest appointments

More from appointments
Approximately 2 fully matching, plus 45 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 11 fully matching, plus 15 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Market Access Transformation

Market Access Transformation (MAT), founded by industry veterans Baiju Aurora and Paul Howard, specializes in developing cutting edge technologies that...

Latest intelligence

Kulveer Singh
Surviving cancer: a new era for patients
Now more than ever, a shift in perspective is needed...
Crisis? No problem!
Issues planning & management for pharma spokespeople, by Andrew Smith...
Are patient recruitment and retention rates rising or falling?
First up, the good news. Over the past seven years, clinical trial recruitment rates have been on the rise....

Infographics